Advion Biosciences Breaks Ground on New Global Headquarters Facility at Cornell Business & Technology Park
July 6, 2006 — ITHACA, N.Y., July 6, 2006 — Advion BioSciences, Inc., a leading provider of Bioanalytical services and products to the pharmaceutical and biotech industry, today broke ground on its new and expanded global headquarters and operating facility. The facility will dramatically expand the company’s laboratory space, provide for co-location with the Systems and Consumables business and accommodate continued growth in the future. The facility is scheduled for completion in May 2007, and is currently under construction at 19 Brown Road in the Cornell Business and Technology Park (CBTP), adjacent to the Tompkins County Airport.
“This is an exciting period for the company,” said Dave Patteson, Advion President and CEO. “Our growth has been notable and we needed a way to increase our capacity and yet be more efficient in a build-to-suit structure. The new HQ is expected to yield a much better customer and employee atmosphere, have better workflow and allow the company to function with better communications, internally and externally. The support we have received from the community, Cornell and local stakeholders has been exemplary.”
John Majeroni, Director of Real Estate at Cornell commented: “Advion is the company that every community dreams of—great paying jobs, strong ties to the community, a technology-based, service-oriented business that can thrive in a small but highly educated city. The company has grown from its two founders to employ more than 140 persons, and this new facility will enable them to grow even more. There are many links between Advion and Cornell University and we here at Cornell are excited that there is now one more.”
Founded in 1993 and based in Ithaca, NY by Dr. Jack Henion and Mr. Thomas Kurz, Advion BioSciences, Inc. is recognized as a world leader in Bioanalytical services, Systems and Consumables for the Life Science industry. Advion BioServices delivers scientific excellence with unparalleled service to the pharmaceutical industry worldwide. In addition to customized LC/MS/MS method development, validation, and sample analysis services, Advion BioServices also offers Sample Management, Metabolism, Biomarker, and Discovery services.
Advion BioSystems’ proprietary instrument products employ novel chip-based nano-electrospray technology to improve the analytical information generated from conventional commercially available Mass Spectrometry systems. This combination provides enhanced analyses of proteins, post-translational modifications, biomarkers, lipids, and metabolites.
Ms. Amy Boardman